Guardant Health to Participate in Upcoming August Investor Conferences
REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced the company will be […]
AnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates
Interim 8-Week Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Did Not Demonstrate Statistical […]
Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
FLORHAM PARK, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the […]
TORM plc to announce second quarter and first half 2020 results
TORM plc (“TORM” or the “Company”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) […]
Rubius Therapeutics Reports Second Quarter 2020 Financial Results and Positive Progress Across Pipeline
Strong Momentum in Dosing Patients and Manufacturing Clinical Supply for RTX-240 Phase 1/2 Solid Tumor Clinical TrialInvestigational New Drug Application on […]
Vaxart Announces IND Filed for COVID-19 Vaccine
SOUTH SAN FRANCISCO, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines […]
Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Announces completion of enrollment in the pivotal Phase 3 NEPTUNE trial with OV101 in Angelman syndrome; topline results expected in […]
Enphase Energy Powers Commercial Business for REAL Solar of Minneapolis
FREMONT, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s […]
Krystal Biotech Reports Second Quarter 2020 Financial Results and Provides Update on Operational Progress
Initiated the pivotal GEM-3 clinical study evaluating B-VEC in DEB patients Today announced enrollment of 1st patient in Phase 2 clinical […]
TSX News -
US FDA Approves Spectral Medical’s Protocol Amendment for TIGRIS
Protocol Amendment allows for increase in TIGRIS sites to 15 while potentially accelerating patient enrolling and offsetting any COVID-19 pandemic-related […]
